Bio-link Australia Pty. Ltd.

News

Please find below a list of selected recent news and press releases from Bio-Link, our clients and the industry. Please select a specific news list for each source from the buttons on the left hand side.

12th October, 2011 – Deal Announcement – Clathrin Inhibitors

Bio-Link has facilitated a global licence, supply and distribution agreement for the first rationally designed clathrin inhibitors. The deal between Freie Universitaet Berlin,  Children’s Medical Research Institute,  University of Newcastle and Ascent Scientific (United Kingdom) covers inclusion of these compounds in Ascent’s catalogue for research uses ..more

25th July 2011 – Deal Announcement

Bio-Link has facilitated a commercial partnership between Capital Biosciences Inc. (USA) and the Children’s Medical Research Institute for a new testing service based on the analysis of telomere maintenance. Click here for the full press release.

15th March 2011 – Deal Announcement

Bio-Link has facilitated a global licence, supply and distribution agreement for a range of small molecule dynamin inhibitors for research purposes, between the Children’s Medical Research Institute and University of Newcastle, and Ascent Scientific (United Kingdom) a multinational provider of high quality receptor ligands and synthetic chemistry services. Click here for the full press release…

17th February 2010 – Bio-Link Engaged by QRxPharma

Bio-Link has been engaged by QRxPharma to assist in partnering the TorsinA Drug Discovery Program for Protein Misfolding Diseases. Lead indications are Parkinson’s disease and early-onset torsion dystonia. QRxPharma is the exclusive licensee of the Program, which is located at the University of Alabama.